Search
for
Sort by
Research 241–270 of 1000+
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- Taurine, a non-proteinous essential amino acid for human body systems: an overview
- Polycystic ovary syndrome: Diagnosis and management
- Referee report. For: Practices, awareness, and perception towards home-based COVID-19 management among the general population in Mangalore city in south India [version 2; peer review: 1 approved, 1 approved with reservations]
- Referee report. For: Practices, awareness, and perception towards home-based COVID-19 management among the general population in Mangalore city in south India [version 2; peer review: 2 approved]
- Vitamin D status in polycystic ovary syndrome
- Changes in bone mineral density in women with early-onset androgenetik alopecia and their correlations with hair-loss stages: a cross-sectional study
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
- Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
- Cardiovascular risk factors in young Czech females with polycystic ovary syndrome
- Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome
- Cardiovascular Toxicities of Androgen Deprivation Therapy
- Cardiovascular risk factors and events in women with androgen excess
- Cardiovascular risk in patients with alopecia areata (AA): A propensity-matched retrospective analysis
- Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors?
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- Cardiovascular effects of hormone therapy for prostate cancer
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Cardiovascular toxicity of minoxidil in the marmoset
- Relationship between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Koreans
- Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk
- Cardiovascular Disease-Associated Skin Conditions
- Inflammatory markers and Lp(a) levels as cardiovascular risk factors in androgenetic alopecia
- Association of Primary Cicatricial Alopecia with Subsequent Cardiovascular Disease
- Cardiovascular risk markers and thyroid status in young Indian women with polycystic ovarian syndrome: A case-control study
- Clinical, laboratory and psychological aspects of moderate COVID-19 in cardiovascular patients one month after discharge from the hospital